Medpace Holdings (NASDAQ: MEDP) reported Q4 EPS of $2.46, $0.24 better than the analyst estimate of $2.22. Revenue for the quarter came in at $498.4 million versus the consensus estimate of $498.84 million.

GUIDANCE:

Medpace Holdings sees FY2024 revenue of $2.15-2.2 billion, versus the consensus of $2.18 billion.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.